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doi:10.1016/j.jfma.2012.01.002Background/Purpose: To evaluate the long-term oncological outcomes of hand-assisted
retroperitoneoscopic radical nephrectomy (HARRN) for treating clinically localized renal cell
carcinoma.
Methods: We retrospectively collected and analyzed the data and clinical outcomes of 46
patients who underwent HARRN and 50 patients who underwent conventional open radical
nephrectomy (ORN) at our institution for clinical localized renal cell carcinoma (RCC).
Results: The median follow-up period of the HARRN group was 56.5 months (range: 14.6e78.7
months); for the ORN group, the median follow-up period was 110.8 months (range: 15.5e123
months). Patient age, sex, body mass index, pathologic parameters, and classification based on
the guidelines of the American Society of Anesthesiologists were not significantly different
between the two groups. The HARRN group had a significantly longer operative time (218
minutes vs. 178 minutes, p Z 0.003) and less blood loss (203 mL vs. 670 mL, p < 0.001).
The complication rates of the ORN and HARRN groups were similar (8% and 4.3%, respectively,
p Z 0.46). No conversions to an open procedure or intraoperative mortality occurred in the
HARRN group. The disease-free and disease-specific survival rates were comparable between
the two groups.
Conclusion: The results of our study indicate that HARRN is a feasible, minimally invasive
treatment for managing clinically organ-confined RCC with a good long-term oncological
outcome.
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42 S.-F. Hung et al.Introduction K.H.H.), and the open radical nephrectomies (ORN) wereLaparoscopic nephrectomy has gained popularity and is
becoming a first-choice treatments for renal malignancy in
many institutes around the world because of its advantages
compared with open surgery, including decreased blood
loss, improved cosmetics, and rapid convalescence.1
Several centers have reported their experiences of using
hand-assisted techniques for laparoscopic nephrectomy
since 1994.2e4 Although the advantages and disadvantages
of hand-assisted procedures have been discussed at length,
this surgical technique has been established for surgeons
as an alternative choice.5e7 Hand assistance is beneficial
if intact specimen removal is required, if the operation is
expected to be difficult, if the laparoscopic surgeon is
inexperienced in the use of hand-assisted devices, or if the
patient’s medical comorbidities mandate a rapid proce-
dure.8 The oncological prognosis of patients treated by
laparoscopic radical nephrectomy has been reported.6,9e11
These studies all indicate that the clinical outcomes did not
differ from those of patients treated using the conventional
open procedure. We have reported the experience at
our institute of using the transperitoneal hand-assisted
approach, and the long-term oncologic outcomes are
comparable with other published works.4,12e15 Recently,
Kawauchi et al reported in a multicenter study that
retroperitoneoscopic hand-assisted radical nephrectomy
provides similar oncological results to the conventional
technique16; in contrast, we evaluated the long-term
oncologic outcomes of hand-assisted retroperitoneal lapa-
roscopic radical nephrectomy (HARRN) in comparison to
that of open radical nephrectomy at a single institute.
Materials and methods
A total of 46 patients with stage T1N0M0 or T2N0M0 renal
cell carcinoma underwent HARRN at National Taiwan
University Hospital between June 2002 and December 2006.
The clinical and follow-up data for these patients were
retrospectively compared with those of 50 patients who
underwent open radical nephrectomy between January
1999 and December 2002. The operative techniques have
been previously reported as the nephrectomy part of
a nephroureterectomy.17 In brief, the patients were placed
in a 60 position, with no position changes occurring during
the procedure. We created the retroperitoneal space by
blunt dissection using the nondominant hand and estab-
lished the hand-assist device (Hand-port; Smith and
Nephew, Andover, MA, USA) by way of the Gibson incision.
Two laparoscopic ports were inserted under the guidance of
the retroperitoneal hand and a 30 telescope. The port sites
were positioned under the 12th rib and posterior to the
posterior axillary line. The posterior plane of the kidney
was further dissected along the psoas muscle until the renal
pedicle was identified. The renal artery was first dissected
and then cut before control of the renal vein. The kidney
was then freed from the surrounding structures. Then, the
intact specimen was excised and extracted en bloc from
the hand-port incision.
A total of 46 HARRNs for stage T1N0 or T2N0 renal cell
carcinoma were performed by two surgeons (C.Y. H. andperformed by five surgeons (S.C.C., M. K. L., Y.S. P., S. M. W.,
and H. J. Y.).
The patients were examined with a complete review of
their medical histories, physical examination, chest X-ray,
biochemistry data, and abdominal and pelvic CT every 3e6
months during the first year and every 6 months thereafter
for up to 3 years, while those without recurrence were only
followed yearly. Recurrence was defined as the reappear-
ance of disease, based on imaging studies, and metastasis
was defined as the presence of tumors at sites distant from
the original disease. Disease-specific survival was defined as
no death from renal cell carcinoma, and disease-free
survival was defined as survival with no sign of the
disease. Statistical analyses were performed using
commercially available software. Categorical data such as
gender, tumor laterality, and stage were compared with the
Chi-square test, and continuous data such as age, body
mass index (BMI), and tumor size were compared using
Students t test, respectively. Survival analyses were per-
formed using the Kaplan-Meier analysis with the log-rank
test. Data collection and analysis were approved by
a protocol through the institutional review board of
National Taiwan University Hospital.Results
There were no significant differences in the demographic
data and pathologic features between the two groups
(Table 1). The mean operating time of the HARRN group
(218  73 minutes) was longer than that of the ORN
group (178  55 minutes). The mean estimated blood loss of
the HARRN group (203  221 mL) was significantly less than
that of the open surgery group (670  727 mL; p < 0.0001).
No open conversion was necessary during the performance
of any of the HARRN procedures. The complication rate was
4.3% (2 of 46 patients) in the HARRN group and 8.0% (4 of
50 patients) in the ORN group (Table 2). In the HARRN
group, cervical spinal injury due to endotracheal intubation
manifested as quadriplegia in one patient, who was
subsequently diagnosed with a critical herniation of an
intervertebral disc of the cervical spine (C4 and C5 levels)
and has since undergone rehabilitation. Another patient in
the HARRN group postoperatively developed pneumothorax
and was successfully treated by chest tube insertion and
intensive care. The four cases with complications in the
ORN group were diagnosed as paralytic ileus (Table 2).
The median follow-up period of the HARRN group (56.5
months) was significantly shorter than that of the ORN
group (110.8 months). No port site, incision site, or local
recurrence has since been found in the HARRN group, and
two of the four cases with lung metastases were found at 10
and 17 months postsurgery, both of whom died of meta-
static disease at 14 and 48 months, respectively. Another
one of the four metastatic cases did not develop any
additional metastasis at 1 year after a lobectomy for right
upper lung metastasis, and the other patient received
target therapy to control additional metastases. Three of
five metastatic patients in the ORN group were found to
have metastases at 13, 56, and 95 months and died at 15,
58, 98 months postsurgery, respectively. Another
Table 1 Patient characteristics and pathologic features.
HARRN group
(N Z 46)
ORN group
(N Z 50)
p-Value
Age (yr) 58.8  13.5 58.2  11.0 0.13
BMI (kg/m2) 24.8  3.5 25.1  3.3 0.94
Gender
Male 28 35 0.35
Female 18 15
ASA status (range) 1.7  0.4 1.6  0.7 0.3
Tumor laterality
Left 26 27 0.80
Right 20 23
Tumor stage
T1 38 44 0.46
T2 8 6
Tumor grade
G1 16 19 0.68
G2 25 28
G3 5 3
Histology type
Conventional 40 37 d
Papillary 3 3
Chromophobe 3 0
Mix 0 10
Tumor size (cm) 5.2  2.0 5.0  1.8 0.86
Specimen weight(g) 230  143 249  95 0.33
Key: HARRN Z hand-assisted retroperitoneoscopic radical
nephrectomy; ORN Z open radical nephrectomy; BMI Z body
mass index; ASA Z American Society of Anesthesiologists
classification.
HARRN in organ-confined RCC 43metastatic patient in the ORN group failed to develop any
additional metastases at 4 years after the hepatectomy,
and the last patient lived more than 3 years after radiation
therapy for hilar metastasis of the right lung. No significant
differences were found between the disease-free and
disease-specific survival rates of the HARRN and open
groups (Figs. 1 and 2).Table 2 Intra-operative and post-operative features.
HARRN grou
Estimated blood loss (mL) 203.7  221
operative time (min) 218.2  73.
Diet resumption (days) 2.2  0.9
Mean time to ambulation (days) 3.4  1.3
Mean hospital stay (days) 7.1  1.4
Postoperative morphine requirement (mg) 9.5  8.4
Convalescence (wk) 2.8  1.3
mean follow-up time(mo)(range) 52.1  15.0
complication rate(%) 4.3
Key: HARRN Z hand-assisted retroperitoneoscopic radical nephrectomDiscussion
Although radical nephrectomy is thought to be a risk factor
for the development of chronic kidney disease,18 it is still
the standard treatment for organ-confined renal cell
carcinomas that are more than 4 cm in diameter. Laparo-
scopic radical nephrectomy (LRN) is a safe and less invasive
procedure, and multiple studies have demonstrated its
feasibility for the treatment of organ-confined renal cancer
with an equivalent cancer control efficacy.1, 6,9e11 LRN
demonstrates less morbidity and an earlier return to
activity compared to the open approach. Recently, the
performance of LRN has been expanded. Simmons et al
reported their experience of treating advanced renal cell
carcinoma by LRN and lymph node dissection, and they
indicated that LRN with lymphadenectomy is feasible and
safe.19 In addition, large tumors or venous thrombus do not
limit the application of LRN. 20e22 However, LRN is techni-
cally demanding and has a significantly longer learning
period. In contrast, hand-assisted radical nephrectomy via
the transperitoneal or retroperitoneal approach is associ-
ated with faster surgeries than the conventional LRN. 23, 24
Tactile feedback during HARRN permits the surgeon to
easily manage difficult cases, such as large renal
masses25,26 and inflammatory masses.27 Hand-assisted
procedures also maintain the tactile sensation necessary
to facilitate dissection, traction, and hemostasis by place-
ment of the nondominant hand into the operative field. It
also significantly helps the hands of urologists who have no
advanced laparoscopic training to overcome difficulties
during the procedure. However, the work space required to
perform a retroperitoneoscopic surgery is less than that
required for a transperitoneoscopic surgery, and the land-
mark during the surgery is so unclear that a steep learning
curve is required to be able to perform HARRN well enough
to achieve a similar surgical outcomes.
However, the oncologic outcomes of HARRN are largely
unknown. Kawauchi et al recently reported the oncological
outcomes of HARRN, finding no difference in cancer-specific
survival after a median follow-up of 41 months.16 But, the
published work by Kawauchi et al is a multicenter survey. In
the present study, we analyzed the long-term oncologic
outcomes of HARRN in 46 patients at our institution, and no
differences in the disease-specific survival rate (Fig. 1) or
disease-free survival rate (Fig. 2) were noted during the
median follow-up period of 56 months.p (n Z 46) ORN group (n Z 50) P Value
.0 670.5  727.3 <0.01
5 178.3  55.0 <0.01
3.5  0.9 <0.01
3.2  1.1 0.34
9.6  6.8 0.02
21.8  15.6 <0.01
4.3  1.2 <0.01
101.4  22.4 d
8 0.878
y; ORN Z open radical nephrectomy.
Figure 1 Kaplan-Meier curves of the disease-specific survival rates of the two groups.
Figure 2 Kaplan-Meier curves of disease-free survival rates of the two groups.
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peritoneal approach is that less working space is required
compared with the transperitoneal approach. We might
attribute the cause of longer operation time of HARRN to
the dissection in the narrow retroperitoneal space. In such
a small space, the use of the nondominant hand might be
expected to compromise the oncologic outcome. However,
the prognosis of the patients treated by HARRN was not
inferior to that of the patients treated by ORN.
Our long-term oncologic outcomes were similar to those
of the study reported by Kawauchi et al.16 Although the
tumors in the present study were a little larger than those
reported in their study, there seemed to be no significant
difference in the oncologic outcomes. These studies
confirm the efficacy of HARRN in obtaining adequate cancer
control. The limitations of the present study include its
retrospective nature, lack of randomization, and the
inclusion of more surgeons in the ORN group. These biases
could have affected the operation time and disease-specific
survival rate in the ORN group.
Although our complication rates were equal between the
HARRN and ORN groups, great care should be taken when
performing HARRN in order to prevent more hazardous
complications, such as pneumothorax. A long-term learningcurve for HARRN is required to achieve similar operational
results in terms of shorter hospital stays and decreased
surgical comorbidities.
Our results suggest that HARRN permits a technically
adequate intraoperative dissection and intact specimen
removal, which translates into good long-term oncological
outcomes.
Conclusions
The results of our study indicate that HARRN is a feasible,
minimally invasive treatment for managing clinically organ-
confined renal cell carcinoma with good long-term onco-
logical outcomes. The complication rate of HARRN in this
series was equal to traditional ORN, and great care should
be taken when performing HARRN in order to prevent
hazardous complications.
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